bioRxivCell BiologyPreprint
Correlating Protein Aggregate Structure with Cellular Function in Differentiated Muscle Cells: Discriminating Pathogenic from Non-Pathogenic Forms
Sander D. Mallon, Erik BosiD, Vahid SheikhhassaniiD, Milad ShademaniD, Dino Rocca, Lenard M. VoortmaniD, Alireza MashaghiiD, Thomas Harry SharpiD, Vered RaziD
Abstract
Ageing has a major adverse impact on maintaining cellular proteostasis and age-related dysregulation leads to an increase in protein aggregation. Equivalently, the accumulation of aggregated proteins accelerates proteostasis impairment. Accumulation of protein aggregates and impaired proteostasis are hallmarks of ageing-associated neuromuscular disorders and tissue degeneration is predominantly in post-mitotic muscle and neuronal cells. A short alanine expansion mutation in the Poly(A) binding protein nuclear 1 (PABPN1) causes Oculopharyngeal muscular dystrophy (OPMD), a rare age-associated protein aggregation myopathy. PABPN1 is a vital RNA-binding protein but OPMD pathology is limited to skeletal muscles connected to nuclear aggregates. In contrast to the mutant PABPN1, the wild-type PABPN1 forms age-associated non-pathogenic aggregates. We generated an inducible muscle cell models for mutant and wild-type PABPN1 protein aggregation. By combining four different, but complementary, imaging modalities, covering micro- to nanoscale resolutions, we were able to characterise differences in structure and dynamics between pathogenic and non-pathogenic PABPN1 aggregates in differentiated muscle cells. These data allowed us to correlate the structure of aggregates to cellular function, providing important insights into how aggregates lead to cell dysfunction in post-mitotic cells. Graphical summary O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=159 SRC="FIGDIR/small/591067v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@22870corg.highwire.dtl.DTLVardef@d0616borg.highwire.dtl.DTLVardef@abe34dorg.highwire.dtl.DTLVardef@d7f359_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: imaging
- research focus: cell type annotation
- approach: microscopy & imaging analysis
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reduced PABPN1 levels causes cytoskeleton disorganization and aberrant differentiation
V. Raz, E. van der Wal, … B. Kessler·bioRxiv·Jan 15, 2020
- Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics
Allison T. Mezzell, Alexandra M Perez, … Katherine E. Vest·PLoS GeneticsPeer-reviewed·Jan 26, 2026
- Domain-specific regulation of PABPN1 uncouples aggregation from function and enables therapeutic rescue
Milad Shademan, Iolanda Vendrell, … Vered Raz·bioRxiv·Jun 16, 2026
- PABPN1 loss-of-function in oculopharyngeal muscular dystrophy primarily impacts APA-shift in muscle transcripts
Milad Shademan, Hailiang Mei, … Vered Raz·medRxiv·Aug 17, 2023
- Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy.
A. Boulinguiez, J. Dhiab, … C. Trollet·bioRxiv·Jan 12, 2024
- Guanabenz treatment improves Oculopharyngeal muscular dystrophy phenotype
Alberto Malerba, Fanny Roth, … Capucine Trollet·bioRxiv·Jul 24, 2018